If you want to buy semaglutide without insurance in August 2026, the manufacturer sells it to you directly: NovoCare Pharmacy charges $149 a month for the Wegovy pill at 1.5 mg and $349 a month for the Wegovy injection at any dose up to 2.4 mg. New injection patients pay $199 a month for their first two fills through December 31, 2026. The $25-a-month figure in the advertising is not available to you. That number is a copay discount, and it requires commercial drug insurance that already covers the prescription.
That distinction is the most expensive thing to get wrong. Novo Nordisk and Eli Lilly each run two separate programs under similar-sounding names, and only the cash-pay one is open to you. Every figure below comes from the manufacturers' own published price guides, current as of August 2026.
The savings card and the self-pay price are different programs
A savings card buys down a copay. With no plan there is no copay, so the card has nothing to work with. Novo's own price guides say it plainly: the $25 tier sits under a heading reading "Copay with commercial insurance." The self-pay prices are a separate block on the same page.
| Your situation | Program that applies | What you pay |
|---|---|---|
| Commercial insurance covering Wegovy or Ozempic | Savings offer copay tier | As little as $25/mo, capped at $100/mo in savings |
| Commercial insurance that excludes it | Self-pay price, run outside the plan | $349/mo injection, $149/mo pill |
| No insurance at all | Self-pay price via NovoCare Pharmacy | $349/mo injection, $149/mo pill |
| Medicare or Medicaid | Excluded from the savings card | $50/mo Medicare GLP-1 Bridge, or the self-pay price |
The self-pay lane is not restricted to the uninsured. It is open to anyone willing to run the prescription without a plan attached, which is why Medicare and Medicaid beneficiaries can use it even though the $25 tier excludes them. The trade-off: that money does not count toward a deductible or an out-of-pocket maximum. Card-by-card rules are on the Wegovy savings card and Ozempic savings card pages.
What semaglutide costs in cash, dose by dose
NovoCare Pharmacy's published self-pay prices, from the Wegovy price guide dated April 2026 and the Ozempic price guide dated May 2026. One month means one box of four pens, or one bottle of 30 tablets.
| Product | Dose | Self-pay price |
|---|---|---|
| Wegovy pill | 1.5 mg, and 4 mg through Aug 31, 2026 | $149/mo (4 mg then $199) |
| Wegovy pill | 9 mg and 25 mg | $299/mo |
| Wegovy pen | 0.25 or 0.5 mg, first 2 fills, new patients | $199/mo through Dec 31, 2026 |
| Wegovy pen | 0.25 to 2.4 mg, standard | $349/mo |
| Wegovy HD pen | 7.2 mg | $399/mo |
| Ozempic pill | 1.5 / 4 / 9 mg | $149 / $199 / $299 per month |
| Ozempic pen | 0.25 or 0.5 mg, first 2 fills, new patients | $199/mo through Dec 31, 2026 |
| Ozempic pen | 0.25 to 1 mg standard, then 2 mg | $349/mo, then $499/mo |
Two things changed the map this year. The Wegovy pill, oral semaglutide 25 mg, was approved on December 22, 2025 and launched in January 2026, which is why an oral obesity dose exists at all. Then in May 2026 Novo retired the Rybelsus name and rebranded oral semaglutide for type 2 diabetes as the Ozempic pill, so any Rybelsus quote you are working from is stale. See semaglutide tablets price.
For contrast, the retail counter with no program attached runs about $1,349 a month for Wegovy and roughly $1,000 for Ozempic. Novo said on February 24, 2026 that it will cut those list prices to $675 on January 1, 2027, still well above every cash program here. Full breakdown at semaglutide price.
TrumpRx is a shop window, not a pharmacy
TrumpRx.gov lists the Wegovy pill at $149, the Wegovy pen at $199, Ozempic at $199 and Zepbound at $299 a month, against original prices of $1,349, $1,349, $1,028 and $1,087. The site dispenses nothing. It links out to the manufacturer's own pharmacy, which for semaglutide is NovoCare, so you land in the programs above.
Those are starting-dose and new-patient numbers. The $199 pen figure is the two-month introductory rate, not maintenance, so budget for $349 by month three.
A 12-month commitment takes the injection to $249
On March 31, 2026 Novo launched a multi-month subscription for self-pay Wegovy patients, sold through telehealth partners rather than directly.
| Commitment | Wegovy pen | Wegovy pill |
|---|---|---|
| 3 months | $329/mo | $289/mo |
| 6 months | $299/mo | $269/mo |
| 12 months | $249/mo | $249/mo |
Ro, WeightWatchers and LifeMD carried it at launch, with Hims & Hers and Sesame following. The saving is real, up to $1,200 a year on the pen, but you are prepaying for a drug you may not tolerate. Early discontinuation is common enough that three months is the safer first commitment. Compare routes at cheapest semaglutide.
The telehealth membership fee is a second bill
Platforms sell the same NovoCare-supplied branded drug at the same NovoCare price, then charge a membership on top. Hims & Hers announced Wegovy availability on March 26, 2026 at cash-pay prices starting at $149 a month. Its weight loss membership is $39 for the first month and auto-renews at $149, and medication is not sold without an active membership. So the $199 Wegovy pen is $238 in month one and $348 a month afterwards.
Get the membership fee, renewal price and cancellation terms in writing before signing up, and check whether cancelling the medication also cancels the membership. It usually does not. More at semaglutide online.
LillyDirect prices the tirzepatide side within $100
If you are choosing a molecule rather than a brand, the cash gap is narrow. Lilly cut Zepbound single-dose vial prices on December 1, 2025: $299 a month at 2.5 mg, $399 at 5 mg, and $449 for 7.5 mg through 15 mg. The KwikPen self-pay program mirrors those figures.
One condition matters. To hold $449 at 7.5 mg and above, Lilly requires a refill within 45 days of the delivery date of your previous fill, or that fill reverts to the standard, higher self-pay price. Set a calendar reminder.
So maintenance semaglutide is $349 and maintenance tirzepatide $449, both direct from the manufacturer. See tirzepatide cost. One correction to a common search: there is no oral tirzepatide, from anyone, at any price. Lilly's pill is Foundayo (orforglipron), approved April 1, 2026, a different molecule, self-pay from $149 a month at the lowest dose.
Compounded semaglutide is no longer the cheap lane
The FDA declared the semaglutide injection shortage resolved, and enforcement discretion ended on April 22, 2025 for state-licensed 503A pharmacies and May 22, 2025 for 503B outsourcing facilities. Semaglutide is on neither the shortage list nor the 503B bulks list.
In an April 1, 2026 update the FDA restated its test: a compounded product with the same active ingredient as an available drug, in the same or an easily substitutable strength, by the same route, is essentially a copy. That covers semaglutide combined with vitamin B12 where the strengths land within 10% of the commercial products. FDA added that it does not currently intend to act against a compounder filling four or fewer prescriptions of such a product per calendar month. That is the size of the remaining lane: individual, prescriber-documented, not a subscription business. Against branded cash prices of $149 to $349, the discount that justified the risk has largely gone.
Three things that are not a route
Research-chemical vendors selling "semaglutide, research use only, not for human consumption" are not a cheap pharmacy. FDA has warned companies for selling exactly these products to consumers with dosing instructions, and runs an import alert on GLP-1 active ingredients with quality concerns. The material is not approved for human use, and a certificate of analysis supplied by the seller is not independent testing.
There is no FDA-approved generic semaglutide in the United States. Apotex received tentative ANDA approval in April 2026, but tentative means patents block launch. Anything sold as "generic semaglutide" today is compounded or unapproved. See semaglutide generic.
There is no over-the-counter semaglutide either. Every route above needs a prescription, and Wegovy's label limits it to obesity, or overweight at a BMI of 27 or above with at least one weight-related condition.
Frequently Asked Questions
Can I get the $25 Wegovy price without insurance?
No. The $25 tier is a copay reduction requiring commercial drug insurance that covers the prescription, capped at $100 a month in savings. Without a plan your price is $349 a month for the injection, $149 for the 1.5 mg pill, or $199 a month for your first two injection fills as a new patient through December 31, 2026.
What is the cheapest way to buy semaglutide without insurance?
The Wegovy pill at 1.5 mg for $149 a month through NovoCare Pharmacy, if an oral starting dose suits you. For the injection, a 12-month self-pay subscription through a NovoCare telehealth partner is $249 a month against $349 buying month to month.
Do I still need a prescription if I am paying cash?
Yes. NovoCare Pharmacy, LillyDirect and every telehealth platform require a valid prescription from a licensed clinician. Paying cash changes who pays, not whether the drug is prescription-only.
Is Ozempic or Wegovy cheaper for an uninsured buyer?
They match at most doses: $349 a month standard, $199 for the first two fills for new patients. The difference is at the top. Ozempic 2 mg is $499 a month, while Wegovy holds $349 up to 2.4 mg, with the 7.2 mg HD pen at $399.
Does paying the self-pay price count toward my deductible?
No. Self-pay prescriptions are processed outside insurance, so they do not count toward a deductible or an out-of-pocket maximum. If you have a high-deductible plan that does cover the drug, run both numbers before choosing.
Sources
- Wegovy price guide, self-pay and commercial copay tiers, April 2026 — NovoCare
- Ozempic pill and pen price guide, May 2026 — NovoCare
- What to pay for Wegovy — Novo Nordisk
- Novo Nordisk launches multi-month subscription program for Wegovy — PR Newswire
- Novo Nordisk announces US list price reduction for semaglutide medicines — PR Newswire
- Wegovy pill FDA approval — Novo Nordisk
- Wegovy pill and pen now available with Hims & Hers — Hims & Hers Newsroom
- Zepbound coverage and savings, including self-pay card terms — Eli Lilly
- Lilly lowers the price of Zepbound single-dose vials — Eli Lilly
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize — FDA
- FDA's concerns with unapproved GLP-1 drugs used for weight loss — FDA
- TrumpRx — US Government
